ASX Share rice
Mon 28 Sep 2020 - 09:21:am (Sydney)

NSB Share Price

NEUROSCIENTIFIC BIOPHARMACEUTICALS LTDNSBPharmaceuticals, Biotechnology & Life Sciences

NSB Company Information

Name:

NeuroScientific Biopharmaceuticals Limited

Sector:

Healthcare

Industry:

Biotechnology

GIC Industry:

Biotechnology

GIC Sub Industry:

Biotechnology

Address:

45 Stirling Highway Nedlands WA Australia 6009

Phone:

61 8 6382 1800

CEO, MD & Director:

Mr. Matthew Liddelow B.Sc.

CFO & Company Sec.:

Ms. Abby Macnish Niven B.Com., B.Sc., C.F.A.

Exec. Director:

Dr. Anton Uvarov Ph.D., BioChem, MBA, MedGen

Company Overview:

NeuroScientific Biopharmaceuticals Limited develops diagnostic and therapeutic treatments for neurodegenerative diseases through preclinical studies of patented technologies. The company's lead drug candidates include EmtinB for treatment of neurodegenerative dementia and Alzheimer's disease, and degenerative conditions of the optic nerve. NeuroScientific Biopharmaceuticals Limited was incorporated in 2002 and is based in Nedlands, Australia.

NSB Share Price Information

Shares Issued:

78.39M

Market Capitalisation:

$21.95M

Revenue (TTM):

$76.27K

Revenue Per Share (TTM):

$0

Earnings per Share:

$-0.023

Operating Margin (TTM):

$-38.56

Return On Assets (TTM):

$-0.41

Return On Equity (TTM):

$-0.66

Quarterly Revenue Growth (YOY):

-0.361

Gross Profit(TTM):

$-31,906

Diluted Earnings Per Share (TTM):

$-0.037

NSB CashFlow Statement

CashFlow Date:

2020-06-30

Investments:

$-2,382

Change To Liabilities:

$18.43K

Total Cashflow From Investing Activities:

$-2,380

Net Income:

$-2,868,528

Total Cash From Operating Activities:

$-2,281,230

Sale Purchase Of Stock:

$0.96M

Capital Expenditures:

$2.38K

NSB Income Statement

Income Date:

2020-06-30

Income Before Tax:

$-2,868,530

Net Income:

$-2,868,530

Operating Income:

$-2,865,110

Interest Expense:

$3.42K

Total Revenue:

$76.27K

NSB Balance Sheet

Balance Sheet Date:

2020-06-30

Intangible Assets:

$422.29K

Total Liabilities:

$88.53K

Total Stockholder Equity:

$3.65M

Total Assets:

$3.74M

Common Stock:

$11.72M

Retained Earnings:

$-8,066,360

Cash:

$3.29M

Total Current Liabilities:

$88.53K

Property - Plant & Equipment:

$9.44K

Net Tangible Assets:

$3.23M

Total Current Assets:

$3.31M

Net Receivables:

$19.13K

Short-Term Investments:

$431.72K

Accounts Payable:

$61.59K

Short-Term Investments:

$431.72

Non Current Liabilities Total:

$0

NSB Share Price History

NSB News

21 Apr, 2020
Passive investing in index funds can generate returns that roughly match the overall market. But one can do better...
14 Jan, 2020
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
03 Oct, 2019
It hasn't been the best quarter for NeuroScientific Biopharmaceuticals Limited (ASX:NSB) shareholders, since the share...